Shanghai Haohai Biological Technology Co (SHSE:688366) Total Equity: ¥5,600 Mil (As of Mar. 2026)


SHSE:688366 Shanghai Haohai Biological Technology Co Ltd SHSE:688366
69 GF Score
Price ¥31.04
GF Value ¥46.11
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Haohai Biological Technology Co Total Equity?

Shanghai Haohai Biological Technology Co SHSE:688366 +1.27% 69 Total Equity is ¥5,600 Mil as of Mar. 2026. GuruFocus rates SHSE:688366 with a GF Score™ of 69/100 and a GF Value™ of ¥46.11 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Shanghai Haohai Biological Technology Co's total equity for the quarter that ended in Mar. 2026 was ¥5,600 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Shanghai Haohai Biological Technology Co Total Equity Historical Data

* Premium members only.

The historical data trend for Shanghai Haohai Biological Technology Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Haohai Biological Technology Co Total Equity Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,060.29 5,902.38 6,017.29 5,917.04 5,604.50

Shanghai Haohai Biological Technology Co Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,917.04 5,882.26 5,884.41 5,604.50 5,600.45
SHSE:688366
69GF Score
Shanghai Haohai Biological Technology Co Ltd SHSE:688366
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Haohai Biological Technology Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Shanghai Haohai Biological Technology Co's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=6720.063-1115.56
=5,605

Shanghai Haohai Biological Technology Co's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=6666.309-1065.858
=5,600

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ¥5,600 Mil mean?
Shanghai Haohai Biological Technology Co (SHSE:688366) has a Total Equity of ¥5,600 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Shanghai Haohai Biological Technology Co and its competitors.
Is Shanghai Haohai Biological Technology Co's Total Equity too high?
Shanghai Haohai Biological Technology Co's current Total Equity is ¥5,600 Mil. Overall, Shanghai Haohai Biological Technology Co has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Haohai Biological Technology Co's Total Equity compare to VRTX and REGN?
Shanghai Haohai Biological Technology Co's Total Equity of ¥5,600 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Shanghai Haohai Biological Technology Co and its competitors. Shanghai Haohai Biological Technology Co's current Total Equity is ¥5,600 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Haohai Biological Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Haohai Biological Technology Co (SHSE:688366) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥46.11, compared to a current price of ¥31.04 — trading 32.7% below its estimated fair value. The current Total Equity is ¥5,600 Mil. Shanghai Haohai Biological Technology Co's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Shanghai Haohai Biological Technology Co (SHSE:688366), the current Total Equity is ¥5,600 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Haohai Biological Technology Co (SHSE:688366) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Haohai Biological Technology Co stock appears to be undervalued. The current stock price of ¥31.04 is trading 32.7% below its estimated GF Value™ of ¥46.11. GuruFocus considers Shanghai Haohai Biological Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:688366:

  • Total Equity: ¥5,600 Mil
  • GF Value™: ¥46.11 vs. price of ¥31.04 (32.7% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688366 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Haohai Biological Technology Co Business Description

Other Exchanges 06826:Hong Kong5HB:Germany
Address No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to a single operating segment, which is the manufacture and sale of biologicals, medical hyaluronate, and intraocular lenses, research and development of biological engineering and pharmaceutical products, and the provision of related services. Its products are categorized into four types, comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China, which is the key revenue driver, the United States, the United Kingdom, and other countries.
69GF Score

Get the complete analysis for SHSE:688366

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥31.04
Price
¥46.11
GF Value